Hosted on MSN1mon
Pliant Therapeutics appoints new Chief Technical Officer
Dr. Imbert, with a 25-year track record in drug development and manufacturing, will oversee chemistry, manufacturing, and control (CMC) operations as the company prepares for commercialization.
Mena FN1mon
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. As Chief Technical Officer
(MENAFN- GlobeNewsWire - Nasdaq) Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 ...